Billy Jebaraj, PhD

Division of CLL, Department of Internal Medicine III, University Hospital Ulm, Germany

Poster(s):

• 1425 - IGLV3-21R110 as a prognostic marker for early stage CLL patients – clinical implications in patients treated with BTK inhibitors and diagnostic challenges